[1] Journal of Experimental & Clinical Cancer Research. (IF=11.4). Wanzhen Zhuang, et al. (2024). Tumor-suppressive miR-4732-3p is sorted into fucosylated exosome by hnRNPK to avoid the inhibition of lung cancer progression. 【miRNA mimics & inhibitor，siRNA，双荧光素酶报告质粒┃肺癌，miRNA抑癌】.

[2] Cell Death & Disease. (IF=8.1). Junfan Pan, et al. (2024). CHAC1 blockade suppresses progression of lung adenocarcinoma by interfering with glucose metabolism via hijacking PKM2 nuclear translocation. 【过表达慢病毒┃肺腺癌，葡萄糖代谢】.

[3] Journal of Translational Medicine. (IF=6.1). Xingyong Chen, et al. (2023). LMP2 deficiency causes abnormal metabolism, oxidative stress, neuroinflammation, myelin loss and neurobehavioral dysfunctions. 【血常规和血液生化┃神经炎症，氧化应激】.

[4] Cell Death Discovery. (IF=6.1). Jingying Wu, et al. (2023). TNF-α contributes to sarcopenia through caspase-8/caspase-3/GSDME-mediated pyroptosis. 【RNAi慢病毒┃肌肉减少症，TNF-α】.

[5] Cell Death Discovery. (IF=6.1). Mingshu Tu, et al. (2023). NSG1 promotes glycolytic metabolism to enhance esophageal squamous cell carcinoma EMT process by upregulating TGF-β. 【siRNA┃食管鳞状细胞癌，EMT】.

[6] Neural Regeneration Research. (IF=5.9). Xingyong Chen, et al. (2024). Activation of the Wnt/β-catenin/CYP1B1 pathway alleviates oxidative stress and protects the blood-brain barrier under cerebral ischemia/reperfusion conditions. 【过表达慢病毒┃脑缺血再灌注，氧化应激】.

[7] Journal of Orthopaedic Translation. (IF=5.9). Hanhao Dai, et al. (2024). Inhibiting uptake of extracellular vesicles derived from senescent bone marrow mesenchymal stem cells by muscle satellite cells attenuates sarcopenia. 【siRNA┃肌肉减少症，细胞外囊泡】.

[8] Frontiers in Immunology. (IF=5.7). Yaqi Zhong, et al. (2024). Deciphering colorectal cancer radioresistance and immune microenvironment: unraveling the role of EIF5A through single-cell RNA sequencing and machine learning. 【siRNA，shRNA慢病毒┃结直肠癌，放疗耐受性】.

[9] Frontiers in Immunology. (IF=5.7). Huadong Wu, et al. (2023). TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion. 【过表达质粒┃头颈鳞癌，免疫逃逸】.

[10] Journal of Cellular and Molecular Medicine. (IF=4.3). Peng Yang, et al. (2023). miR‐221‐3p targets Ang‐2 to inhibit the transformation of HCMECs to tip cells. 【过表达质粒和shRNA质粒┃脑微血管内皮细胞，miRNA】.

[11] Cancer Cell International. (IF=5.3). Kai Ye, et al. (2024). E3 ubiquitin ligase BTBD3 inhibits tumorigenesis of colorectal cancer by regulating the TYRO3/Wnt/β-catenin signaling axis. 【过表达和RNAi慢病毒结┃直肠癌，泛素化】.

[12] Molecular Neurobiology. (IF=4.6). Taotao Lu, et al. (2024). Alisol A exerts neuroprotective effects against HFD-induced pathological brain aging via the SIRT3-NF-κB/MAPK pathway. 【shRNA慢病毒┃脑老化，炎症】.

[13] Respiratory Research. (IF=4.1). Yun Ding, et al. (2021). CYP2J2 and EETs protect against pulmonary arterial hypertension with lung ischemia–reperfusion injury in vivo and in vitro. 【重组腺相关病毒┃肺动脉高压，EETs】.

[14] Aging (Albany NY). (IF=3.9). Xuyang Wang, et al. (2023). PCNT is a prognostic biomarker correlated with tumor immune microenvironment in hepatocellular carcinoma and promotes tumor progression by inhibiting cell cycle arrest. 【shRNA质粒┃肝细胞癌，免疫微环境】.

[15] Scientific Reports. (IF=3.8). Zheng Zheng, et al. (2021). MicroRNA-513b-5p targets COL1A1 and COL1A2 associated with the formation and rupture of intracranial aneurysm. 【KTC-1细胞系，miRNA inhibitor和miRNA mimic合成┃颅内动脉瘤】.

[16] Frontiers in Oncology. (IF=3.5). Lijuan Ke, et al. (2022). ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma. 【HT22细胞系┃甲状腺癌】.

[17] BMC Cancer. (IF=3.4). Qiwei Yao, et al. (2022). CANT1 serves as a potential prognostic factor for lung adenocarcinoma and promotes cell proliferation and invasion in vitro. 【siRNA┃肺腺癌，CANT1】.

[18] Journal of Cancer. (IF=3.3). Huaxiang Wang, et al. (2022). The diagnostic and prognostic significance of small nuclear ribonucleoprotein Sm D1 aberrantly high expression in hepatocellular carcinoma. 【siRNA，miRNA，双荧光素酶报告质粒┃肝细胞癌，核糖核蛋白】.

[19] PLoS One. (IF=2.9). Jingwen Xiao, et al. (2022). MiRNA-1202 promotes the TGF-β1-induced proliferation, differentiation and collagen production of cardiac fibroblasts by targeting nNOS. 【miRNA mimics和miRNA inhibitor┃心脏纤维化】.

[20] European Journal of Medical Research. (IF=2.8). Jie Liu, et al. (2024). MDM4 was associated with poor prognosis and tumor-immune infiltration of cancers. 【THP-1细胞┃MDM4，肿瘤免疫】.

[21] Journal of Orthopaedic Surgery and Research. (IF=2.8). Yuan Lin, et al. (2022). Inhibiting KCNMA1-AS1 promotes osteogenic differentiation of HBMSCs via miR-1303/cochlin axis. 【RNAi慢病毒┃成骨分化】.

[22] Journal of Cancer Research and Clinical Oncology. (IF=2.7). Yan Zhang, et al. (2024). Prognostic implications of TOR1B expression across cancer types: a focus on basal-like breast cancer and cellular adaptations to hypoxia. 【RNAi慢病毒┃乳腺癌，低氧适应】.

[23] Journal of Clinical Laboratory Analysis. (IF=2.6). Yingfeng Jiang, et al. (2022). High expression of DARS2 indicates poor prognosis in lung adenocarcinoma. 【siRNA┃肺腺癌，预后】.

[24] Experimental and Therapeutic Medicine. (IF=2.4). Changlong Fu, et al. (2022). Protective role of Achyranthes bidentata polysaccharides against chondrocyte extracellular matrix degeneration through lncRNA GAS5 in osteoarthritis. 【RNAi慢病毒┃骨关节炎】.

[25] Open Medicine (Warsaw). (IF=1.7). Lijuan Ke, et al. (2022). miR-142-5p promotes cervical cancer progression by targeting LMX1A through Wnt/β-catenin pathway. 【miRNA mimics和miRNA inhibitor┃宫颈癌】.